2023 Q3 Form 10-Q Financial Statement

#000106299323016131 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.915M $2.579M
YoY Change -20.08% -22.04%
% of Gross Profit
Research & Development $6.945M $7.599M
YoY Change 48.46% 101.49%
% of Gross Profit
Depreciation & Amortization $113.4K $63.25K
YoY Change 111.41% 31.16%
% of Gross Profit
Operating Expenses $8.860M $10.18M
YoY Change 25.24% 43.76%
Operating Profit -$8.860M -$10.18M
YoY Change 25.24% 43.76%
Interest Expense $58.06K $41.05K
YoY Change
% of Operating Profit
Other Income/Expense, Net $58.06K $41.05K
YoY Change -235.16% -22.15%
Pretax Income -$8.802M -$10.14M
YoY Change 23.67% 44.25%
Income Tax -$284.9K -$314.6K
% Of Pretax Income
Net Earnings -$8.543M -$9.823M
YoY Change 29.91% 69.1%
Net Earnings / Revenue
Basic Earnings Per Share -$0.11 -$0.13
Diluted Earnings Per Share -$0.11 -$0.13
COMMON SHARES
Basic Shares Outstanding 78.76M shares 75.31M shares
Diluted Shares Outstanding 78.08M shares 75.94M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.76M $15.44M
YoY Change -54.56% -55.94%
Cash & Equivalents $12.76M $15.44M
Short-Term Investments
Other Short-Term Assets $539.5K $696.5K
YoY Change -30.05% -28.22%
Inventory
Prepaid Expenses
Receivables $129.0K $124.7K
Other Receivables $0.00 $0.00
Total Short-Term Assets $13.42M $16.26M
YoY Change -53.61% -55.67%
LONG-TERM ASSETS
Property, Plant & Equipment $2.002M $1.621M
YoY Change 55.18% 26.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $391.7K $350.6K
YoY Change 1858.25% 776.59%
Total Long-Term Assets $81.54M $80.81M
YoY Change 2.18% 3.17%
TOTAL ASSETS
Total Short-Term Assets $13.42M $16.26M
Total Long-Term Assets $81.54M $80.81M
Total Assets $94.97M $97.07M
YoY Change -12.67% -15.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $983.9K $1.621M
YoY Change -29.87% -25.57%
Accrued Expenses $1.051M $935.4K
YoY Change 73.37% 174.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.203M $2.578M
YoY Change 8.31% 1.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $127.3K
YoY Change
Total Long-Term Liabilities $127.3K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.203M $2.578M
Total Long-Term Liabilities $127.3K $0.00
Total Liabilities $2.789M $3.321M
YoY Change -30.06% -34.14%
SHAREHOLDERS EQUITY
Retained Earnings -$33.85M -$25.30M
YoY Change -5068.59% -448.68%
Common Stock $79.07K $76.86K
YoY Change 9.55% 6.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $92.18M $93.75M
YoY Change
Total Liabilities & Shareholders Equity $94.97M $97.07M
YoY Change -12.67% -15.59%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$8.543M -$9.823M
YoY Change 29.91% 69.1%
Depreciation, Depletion And Amortization $113.4K $63.25K
YoY Change 111.41% 31.16%
Cash From Operating Activities -$8.169M -$8.575M
YoY Change 33.37% 38.07%
INVESTING ACTIVITIES
Capital Expenditures $544.0K $515.4K
YoY Change -163.54% 401.17%
Acquisitions
YoY Change
Other Investing Activities -$95.75K $7.390K
YoY Change
Cash From Investing Activities -$639.8K -$508.0K
YoY Change -25.28% 216.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.124M 4.249M
YoY Change 81555.2% 35310.5%
NET CHANGE
Cash From Operating Activities -8.169M -8.575M
Cash From Investing Activities -639.8K -508.0K
Cash From Financing Activities 6.124M 4.249M
Net Change In Cash -2.684M -4.834M
YoY Change -61.51% -23.99%
FREE CASH FLOW
Cash From Operating Activities -$8.169M -$8.575M
Capital Expenditures $544.0K $515.4K
Free Cash Flow -$8.713M -$9.090M
YoY Change 65.37% 43.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
52729 usd
CY2021Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.51 pure
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
36800000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
237136 usd
CY2022Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
1600000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
75687 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
192857 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
dc Withholding Of Employee Tax Payment On Psu
WithholdingOfEmployeeTaxPaymentOnPsu
38000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
333588 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.81
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.39
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1734 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.449 pure

Files In Submission

Name View Source Status
0001062993-23-016131-index-headers.html Edgar Link pending
0001062993-23-016131-index.html Edgar Link pending
0001062993-23-016131.txt Edgar Link pending
0001062993-23-016131-xbrl.zip Edgar Link pending
dc-20230630.xsd Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
form10qxz001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
dc-20230630_cal.xml Edgar Link unprocessable
dc-20230630_def.xml Edgar Link unprocessable
dc-20230630_lab.xml Edgar Link unprocessable
dc-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending